Regarding breast cancer, in addition to the known high-penetrance pathogenic variants of BRCA1/2, mutations in other high- or intermediate-penetrance genes can increase the risk of cancer [21] and the most common non-BRCA pathogenic or likely pathogenic variants affect PALB2, ATM, and CHEK2 genes [22]. This evidence concerns the gene ATM and breast cancer.